JAMA Article Says TAXUS(R) Stents Superior To Brachytherapy In The Treatment Of In-Stent Restenosis

... Boston ScientificCorporation (NYSE: BSX) today welcomed an article in the Journal of theAmerican Medical Association (JAMA) on the TAXUS V ISR (in-stent restenosis)clinical trial that found the TAXUS(R) Express2(TM) paclitaxel-eluting stentsystem achieved superior outcomes in the treatment of in-stent restenosiscompared to those patients treated with radiation-based brachytherapy... click link for more info. ...